Search

Your search keyword '"Abrams, Jeffrey S"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Abrams, Jeffrey S" Remove constraint Author: "Abrams, Jeffrey S" Database Unpaywall Remove constraint Database: Unpaywall
111 results on '"Abrams, Jeffrey S"'

Search Results

2. Preoperative planning with three-dimensional CT vs. three-dimensional magnetic resonance imaging does not change surgical management for shoulder instability

3. Contributors

10. Contributors

12. Surgical treatment for recurrent shoulder instability: factors influencing surgeon decision making

14. Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)

17. Nivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) Study

18. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

21. Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)

26. National Athletic Trainers' Association Position Statement: Evaluation, Management, and Outcomes of and Return-to- Play Criteria for Overhead Athletes With Superior Labral Anterior-Posterior Injuries

29. Abstract A053: Prevalence of mismatch repair deficiency (dMMR) in the NCI Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) population

31. Leading the way: The National Cancer Institute’s (NCI) single IRB for multi-site research.

37. Evaluating year 1 of NCI's experimental therapeutics clinical trials network (ETCTN).

39. Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

40. 2016

41. ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non–Small Cell Lung Cancer

44. Creating a national collaborative strategy to enhance trial accrual in NCI’s National Clinical Trials Network (NCTN) in the era of precision medicine.

45. ALCHEMIST: a clinical trial platform to bring genomic discovery and molecularly targeted therapies to early-stage lung cancer.

46. Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Catalog

Books, media, physical & digital resources